Celestica Q3 Crushes Estimates, Raises Long-Term Targets, But Questions Remain on Profit Quality

What happened

Celestica delivered a blowout Q3 with revenue up 83% YoY and EPS up 109%, driven by surging AI hardware demand, led by the Compute & Storage division which grew 242% and now represents 28% of revenue. Management raised 2026 and 2027 guidance, lifting the 2027 revenue target from $35B to $40B and EPS to $21.50, signaling accelerating growth expectations. These results align with the prior thesis that Celestica is a real AI infrastructure beneficiary, but the report had cautioned that the stock already priced in sustained hyperscaler demand and successful 1.6T switch ramps. The Q3 beat and guidance increase confirm demand strength but do not yet resolve concerns about flat gross margins (12.3% in Q2, with no expansion), rising customer concentration (top 10 at 83%), and the overhang of 9.7% dilution from the August equity raise. The next critical test is whether the 1.6T programs that were supposed to begin in 2H 2026 have actually shipped at scale and whether inventory converts into revenue without further margin erosion, as the company hosts its analyst day and provides Q4 outlook.

Implication

Investors should treat the Q3 beat as confirmation of demand, not as proof that the company can convert scale into profitable per-share growth. The raised 2027 targets imply a significant acceleration in revenue and EPS, but they must be weighed against the 9.7% share dilution already absorbed and the need for gross margin to improve from current levels. The key catalyst remains the 1.6T switch ramp; if management can demonstrate meaningful shipments and revenue contribution in Q4 or early 2027, the bull case strengthens and the stock could justify a higher valuation. Conversely, if inventory continues to grow faster than revenue or if one hyperscaler delays deployment, the bear case of $260 becomes more likely given customer concentration and high capital intensity. For new money, waiting for either a pullback to around $300 or clear evidence of margin expansion and 1.6T ramp execution provides a better risk-reward than chasing the stock after an 83% revenue quarter at 35x earnings.

Thesis delta

The Q3 results and raised guidance modestly increase confidence in the demand trajectory, tilting the probability distribution toward the bull scenario. However, they do not address the core margin and dilution concerns, leaving the WAIT rating and conviction unchanged. The thesis remains that Celestica is a real AI beneficiary, but buying now requires evidence of profitable scale, and the Q3 report provides only partial evidence.